| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC UNSPECIFIED ION MODE | Les-Jas-20190812-13 | Treatment:PBMC | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20190812-14 | Treatment:PBMC | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20190812-15 | Treatment:PBMC | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20200214-03 | Treatment:PBMC | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20200214-04 | Treatment:PBMC | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20190812-16 | Treatment:Tumor | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20190812-17 | Treatment:Tumor | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20190812-18 | Treatment:Tumor | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20200214-01 | Treatment:Tumor | Peak Area |
| HILIC UNSPECIFIED ION MODE | Les-Jas-20200214-02 | Treatment:Tumor | Peak Area |
Return to study ST002935 main page
Download data matrix(Title: Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth HILIC UNSPECIFIED ION MODE)
- Metabolomics Workbench
|